National Research(DE:NR1A)
€23.600.00 (0.00%)
DE:NR1A
National Research financials statements
€23.60
At close:0.00 (0.00%)
National Research (NR1A) Ratios
0 Followers
National Research Ratios
DE:NR1A's free cash flow for Q3 2026 was $6.98M. For the 2026 fiscal year, DE:NR1A's free cash flow was decreased by $-1.04M and operating cash flow was $8.02M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.55 | 0.55 | 0.67 | 1.31 | 1.82 |
| Quick Ratio | 0.55 | 0.55 | 0.67 | 1.31 | 1.82 |
| Cash Ratio | 0.11 | 0.12 | 0.18 | 0.75 | 1.35 |
| Solvency Ratio | 0.16 | 0.30 | 0.50 | 0.63 | 0.61 |
| Operating Cash Flow Ratio | 0.72 | 0.97 | 1.05 | 1.09 | 1.15 |
| Short-Term Operating Cash Flow Coverage | 6.59 | 7.23 | 4.88 | 6.81 | 8.84 |
| Net Current Asset Value | $ -100.68M | $ -81.66M | $ -49.12M | $ -14.71M | $ 1.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.59 | 0.49 | 0.32 | 0.18 | 0.18 |
| Debt-to-Equity Ratio | 5.65 | 2.06 | 0.80 | 0.32 | 0.34 |
| Debt-to-Capital Ratio | 0.85 | 0.67 | 0.44 | 0.25 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.84 | 0.65 | 0.38 | 0.20 | 0.21 |
| Financial Leverage Ratio | 9.64 | 4.24 | 2.50 | 1.81 | 1.85 |
| Debt Service Coverage Ratio | 2.73 | 4.52 | 4.26 | 5.86 | 6.59 |
| Interest Coverage Ratio | 4.74 | 13.56 | 46.46 | 38.50 | 30.16 |
| Debt to Market Cap | 0.19 | 0.15 | 0.04 | 0.02 | 0.03 |
| Interest Debt Per Share | 3.74 | 2.82 | 1.62 | 0.99 | 1.19 |
| Net Debt to EBITDA | 2.48 | 1.46 | 0.70 | -0.03 | -0.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.33% | 60.20% | 62.30% | 62.36% | 64.62% |
| EBIT Margin | 16.45% | 24.66% | 26.98% | 29.05% | 33.99% |
| EBITDA Margin | 22.00% | 28.87% | 30.95% | 32.53% | 38.30% |
| Operating Profit Margin | 16.44% | 24.60% | 26.95% | 30.71% | 33.98% |
| Pretax Profit Margin | 12.99% | 22.85% | 26.90% | 28.25% | 32.86% |
| Net Profit Margin | 8.44% | 17.32% | 20.84% | 20.98% | 25.32% |
| Continuous Operations Profit Margin | 8.44% | 17.32% | 20.84% | 20.98% | 25.32% |
| Net Income Per EBT | 65.01% | 75.81% | 77.50% | 74.27% | 77.06% |
| EBT Per EBIT | 78.99% | 92.89% | 99.79% | 91.99% | 96.72% |
| Return on Assets (ROA) | 8.60% | 18.70% | 25.30% | 24.38% | 23.78% |
| Return on Equity (ROE) | 82.92% | 79.22% | 63.26% | 44.15% | 43.90% |
| Return on Capital Employed (ROCE) | 22.99% | 36.40% | 46.44% | 47.96% | 42.91% |
| Return on Invested Capital (ROIC) | 14.36% | 26.15% | 33.00% | 33.77% | 31.65% |
| Return on Tangible Assets | 17.44% | 38.86% | 52.18% | 47.30% | 39.80% |
| Earnings Yield | 2.76% | 5.92% | 3.19% | 3.42% | 3.55% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.81 | 12.78 | 11.77 | 9.91 | 10.15 |
| Payables Turnover | 14.76 | 47.68 | 43.06 | 49.48 | 26.94 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 3.39 | 3.59 | 4.91 | 8.51 | 11.07 |
| Asset Turnover | 1.02 | 1.08 | 1.21 | 1.16 | 0.94 |
| Working Capital Turnover Ratio | -8.41 | -10.18 | -192.46 | 6.95 | 5.31 |
| Cash Conversion Cycle | 6.18 | 20.91 | 22.53 | 29.46 | 22.42 |
| Days of Sales Outstanding | 30.91 | 28.56 | 31.01 | 36.84 | 35.97 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 24.74 | 7.65 | 8.48 | 7.38 | 13.55 |
| Operating Cycle | 30.91 | 28.56 | 31.01 | 36.84 | 35.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.18 | 1.46 | 1.55 | 1.46 | 1.82 |
| Free Cash Flow Per Share | 0.70 | 0.81 | 0.91 | 1.06 | 1.61 |
| Dividend Paid and CapEx Coverage Ratio | 1.22 | 1.29 | 0.73 | 1.18 | 3.16 |
| Capital Expenditure Coverage Ratio | 2.47 | 2.24 | 2.42 | 3.69 | 8.40 |
| Operating Cash Flow Coverage Ratio | 0.33 | 0.54 | 0.98 | 1.55 | 1.62 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.24 | 0.26 | 0.24 | 0.31 |
| Free Cash Flow Yield | 3.75% | 4.58% | 2.30% | 2.84% | 3.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 36.10 | 16.80 | 31.35 | 29.23 | 28.17 |
| Price-to-Sales (P/S) Ratio | 3.06 | 2.92 | 6.53 | 6.13 | 7.13 |
| Price-to-Book (P/B) Ratio | 30.03 | 13.38 | 19.83 | 12.91 | 12.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 26.69 | 21.82 | 43.47 | 35.17 | 25.85 |
| Price-to-Operating Cash Flow Ratio | 15.88 | 12.08 | 25.47 | 25.63 | 22.78 |
| Price-to-Earnings Growth (PEG) Ratio | -0.72 | -1.01 | -20.06 | -2.26 | -41.70 |
| Enterprise Value Multiple | 16.38 | 11.59 | 21.81 | 18.82 | 18.18 |
| Enterprise Value | 495.02M | 478.61M | 1.00B | 927.95M | 1.03B |
| EV to EBITDA | 16.38 | 11.59 | 21.81 | 18.82 | 18.18 |
| EV to Sales | 3.60 | 3.35 | 6.75 | 6.12 | 6.96 |
| EV to Free Cash Flow | 31.44 | 24.96 | 44.91 | 35.11 | 25.22 |
| EV to Operating Cash Flow | 18.72 | 13.82 | 26.32 | 25.59 | 22.22 |
| Tangible Book Value Per Share | -2.43 | -1.58 | -0.58 | 0.35 | 0.86 |
| Shareholders’ Equity Per Share | 0.63 | 1.32 | 1.99 | 2.89 | 3.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.35 | 0.24 | 0.22 | 0.26 | 0.23 |
| Revenue Per Share | 6.14 | 6.03 | 6.05 | 6.08 | 5.82 |
| Net Income Per Share | 0.52 | 1.04 | 1.26 | 1.28 | 1.47 |
| Tax Burden | 0.65 | 0.76 | 0.78 | 0.74 | 0.77 |
| Interest Burden | 0.79 | 0.93 | 1.00 | 0.97 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.40 | 0.31 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| Income Quality | 2.28 | 1.40 | 1.23 | 1.14 | 1.24 |
Currency in USD

